Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with langerhans cell histiocytosis

Pediatric Blood and Cancer

Volumn 43, Issue 1, 2004, Pages 59-65

  Grois, Nicole ^a   Prayer, Daniela ^a,b   Prosch, Helmut ^a   Minkov, Milen ^a   Pötschger, Ulrike ^a   Gadner, Helmut ^a,c  

^a CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^b University Clinic Vienna   (Austria)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Diabetes insipidus; Histiocytosis; Langerhans cell; Magnetic resonance imaging

Indexed keywords

ADENOHYPOPHYSIS; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONVALESCENCE; DIABETES INSIPIDUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HISTIOCYTOSIS X; HORMONE DEFICIENCY; HUMAN; INFUNDIBULUM; MAJOR CLINICAL STUDY; MALE; MONITORING; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; BONE DISEASES; CHILD; CHILD, PRESCHOOL; DIABETES INSIPIDUS, NEUROGENIC; DISEASE PROGRESSION; FACIAL BONES; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES; PITUITARY GLAND; RETROSPECTIVE STUDIES;

EID: 2942525850     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20003     Document Type: Review

References (27)

1. Grois N, Flucher-Wolfram B, Heitger A, et al. Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study. Med Pediatr Oncol 1995;24:248-256.
2. Dunger DB, Broadbent V, Yeoman E, et al. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis. N Engl J Med 1989;321:1157-1162.
3. The French Langerhans' Cell Histiocytosis Study Group: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17-24.
4. Grois N, Favara B.E, Mostbeck G, et al. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin N Am 1998;12:287-305.
5. Colombo N, Berry I, Kucharczyck J, et al. Posterior pituitary gland: Appearance on MR images in normal and pathologic states. Radiology 1987;165:481-485.
6. Fujisawa I, Nishimura K, Asato R, et al. Posterior lobe of the pituitary in diabetes insipidus: MR findings. J Comput Assist Tomogr 1987;11:221-225.
7. Gudinichet F, Brunelle F, Barth MO, et al. MR imaging of the posterior hypophysis in children. AJNR 1989;153:351-354.
8. Tien RD, Newton TH, McDermott MW, et al. Thickened pituitary stalk on MR images in patients with diabetes insipidus and Langerhans cell histiocytosis. AJNR Am J Neuroradiol 1990;11: 703-708.
9. Tien RD, Kucharczyk J, Kucharczyk W. MR imaging of the brain in patients with diabetes insipidus. AJNR Am J Neuroradiol 1991; 12:533-542.
10. Asano T, Goto Y, Kida S, et al. Isolated histiocytosis X of the pituitary stalk. J Neuroradiol 1999;26:277-280.
11. Grois N, Tsunematsu Y, Barkovich AJ, et al. Central nervous system disease in Langerhans cell histiocytosis. Br J Cancer 1994; Suppl XXXIII:S24-S28.
12. Mazal PR, Hainfellner JA, Preiser J, et al. Langerhans cell histiocytosis of the hypothalamus: Diagnostic value of immunohistochemistry. Clin Neuropath 1996;15:87-91.
13. Maghnie M, Villa A, Arico M, et al. Correlation between magnetic resonance imaging of posterior pituitary and neurohypophyseal function in children with diabetes insipidus. J Clin Endocrinal Metab 1992;74:795-800.
14. Minehan KJ, Chen MG, Zimmermann D, et al. Radiation therapy for diabetes insipidus caused by Langerhans' cell histiocytosis. Int J Radiat Oncol Biol Phys 1992;23:519-524.
15. Kaltsas GA, Powles TB, Evanson J, et al. Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: Clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000;85:1370-1376.
16. Rosenzweig KE, Arceci RJ, Tarbell NJ. Diabetes insipidus secondary to Langerhans' cell histiocytosis: Is radiation therapy indicated? Med Pediatr Oncol 1997;29:36-40.
17. Broadbent V, Pritchard J. Diabetes insipidus associated with Langerhans cell histiocytosis: Is it reversible? Med Pediatr Oncol 1997;28:289-293.
18. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 1994;23:72-80.
19. Gadner H, Grois N, Arico M, et al. LCH-I: A randomized trial of treatment of multisystem Langerhans cell histiocytosis. J Pediatr 2001;138:728-734.
20. LCH-II Study Committee. LCH-II Treatment Protocol of the Second International Study for Langerhans Cell Histiocytosis 2001.
21. LCH-III Study Committee. LCH-III Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis 2001.
22. Ladisch S, Gadner H. Treatment of Langerhans cell histiocytosis - Evolution and current approaches. Br J Cancer 1994;70:41-46.
23. Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000;343:998-1007.
24. Elster AD. Modern imaging of the pituitary. Radiology 1993;187: 1-14.
25. Mootha SL, Barkovich AJ, Grumbach MM, et al. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 1997;82:1362-1367.
26. Grois NG, Favara BE, Mostbeck GH, et al. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin N Am 1998;12:287-305.
27. Histiocyte Society. LCH-CNS 2000 study protocol, Central nervous system disease in Langerhans cell histiocytosis 2000.